CLINICAL CASE OF C1Q – NEPHROPATHY
https://doi.org/10.24884/1561-6274-2012-16-3/1-117-121
Abstract
Clinical case of C1Q – nephropathy.
About the Authors
M. M. Batyushin
Ростовский государственный медицинский университет
Russian Federation
Russian Federation
A. A. Galushkin
Ростовский государственный медицинский университет
Russian Federation
Russian Federation
D. G. Pasechnik
Ростовский государственный медицинский университет
Russian Federation
Russian Federation
A. S. Litvinov
Ростовский государственный медицинский университет
Russian Federation
Russian Federation
M. Z. Gasanov
Ростовский государственный медицинский университет
Russian Federation
Russian Federation
N. A. Sadovnichaya
Ростовский государственный медицинский университет
Russian Federation
Russian Federation
D. S. Tsvetkov
Ростовский государственный медицинский университет
Russian Federation
Russian Federation
References
1. Jennette JC, Hipp CG. C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis 1985; 6: 103–110
2. Nachman PH, Jennette JC, Falk RJ. Primary Glomerular Disease. In 8th ed. Brenner BM: The Kidney. Brenner and Rector’s, 2007; 1006-1007
3. Nishida M, Kawakatsu H, Komatsu H, et al. Spontaneous improvement in a case of C1q nephropathy. Am J Kidney Dis 2000; 35:E22
4. Bohnsack JF, Tenner AJ, Laurie GW et al. The C1q subunit of the first component of complement binds to laminin: a mechanism for the deposition and retention of immune complexes in basement membrane. Proc Nat Acad Sci 1985; 82: 3824–3828
5. van den Dobbelsteen ME, van der Woude FJ, Schroeijers WE et al. Both IgG- and C1q-receptors play a role in the enhanced binding of IgG complexes to human mesangial cells. J Am Soc Nephrol 1996; 7:573–581
6. Fukuma Y, Hisano S, Segawa Y et al. Clinicopathologic correlation of C1q nephropathy in children. Am J Kidney Dis 2006; 47: 412–418
7. Hisano S, Fukuma Y, Segawa Y et al. Clinicopathologic correlation and outcome of C1q nephropathy. Clin J Am Soc Nephrol 2008; 3:1637–1643
8. Iskandar SS, Browning MC, Lorentz WB. C1q nephropathy: a pediatric clinicopathologic study. Am J Kidney Dis 1991; 18: 459–465
9. Markowitz GS, Schwimmer JA, Stokes MB et al. C1q nephropathy: a variant of focal segmental glomerulosclerosis. Kidney Int 2003; 64:1232–1240
10. Kersnik LT, Kenda RB, Avgustin CM et al. C1Q nephropathy in children. Pediatr Nephrol 2005; 20: 1756–1761
11. Lau KK, Gaber LW, Delos Santos N Met al.C1q nephropathy: features at presentation and outcome. Pediatr Nephrol 2005; 20: 744–749
12. Davenport A, Maciver AG, Mackenzie JC C1q nephropathy: do C1q deposits have any prognostic significance in the nephrotic syndrome? Nephrol Dial Transplant 1992; 7: 391–396
13. Sharman A, Furness P, Feehally J Distinguishing C1q nephropathy from lupus nephritis. Nephrol Dial Transplant 2004; 19: 1420–1426
14. Vizjak A, Ferluga D, Rozic M et al. Pathology, clinical presentations, and outcomes of C1q nephropathy. J Am Soc Nephrol 2008; 19: 2237–2244
15. Roberti I, Baqi N, Vyas S et al. Asingle-center study of C1q nephropathy in children. Pediatr Nephrol 2009; 24: 77–82
16. Wong CS, Fink CA, Baechle J et al. C1q nephropathy and minimal change nephrotic syndrome. Pediatr Nephrol 2009; 24: 761–767
Review
For citations:
Batyushin M.M., Galushkin A.A., Pasechnik D.G., Litvinov A.S., Gasanov M.Z., Sadovnichaya N.A., Tsvetkov D.S. CLINICAL CASE OF C1Q – NEPHROPATHY. Nephrology (Saint-Petersburg). 2012;16(3/1):117-121. (In Russ.) https://doi.org/10.24884/1561-6274-2012-16-3/1-117-121
Views:
491
Email this article 